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Background
Spontaneous development of systemic inflammation and
autoimmunity results in brain atrophy and behavioral
dysfunction in lupus-prone MRL-lpr mice. Based on ben-
eficial effects of non-steroidal anti-inflammatory drugs in
other CNS inflammation models, we test the hypothesis
that chronic treatment with ibuprofen (COX-1/COX-2
inhibitor) attenuates behavioral deficits and neuronal loss
in this model of neuropsychiatric lupus.
Materials and methods
To avoid confounding effects of repeated injections on
performance in behavioral tasks, ibuprofen was provided
in rodent chow from 5–19 weeks of age and an estab-
lished behavioral battery was concurrently applied. Neu-
ropathological and immunological parameters were
estimated upon sacrifice using F4/80, CD3, and Fluoro
Jade B (FJB) staining techniques. Transmission electron
microscopy (EM) was also employed to the examine
ultrastructural features of neurodegeneration in murine
brains.
Results
The density of F4/80-positive microglial cells was
increased in brains of MRL-lpr mice fed with the control
diet, but the treatment with ibuprofen neither prevented
this activation nor normalized their behavioral perform-
ance. Similarly, no attenuation in infiltration of CD3-pos-
itive lymphocytes into the choroid plexus or density of
dying (FJB-positive) neurons were seen. Paradoxically,
ibuprofen increased serum levels of TNF-alpha and circu-
lating immune complexes in both MRL-lpr and the less
symptomatic MRL +/+ substrain. However, it did not pro-
mote lymphocyte infiltration into the brain or neurode-
generation in MRL +/+ control mice. EM revealed
numerous dark neurons in MRL-lpr brains, but no evi-
dence of blebbing of the nucleus or apoptotic bodies was
found.
Discussion
Taken together, present results suggest that activation of
COX-dependent inflammatory pathways is not critical in
the etiology of CNS dysfunction in MRL-lpr mice. Further-
more, modest amplification in systemic TNF-alpha levels
do not seem to compromise the permeability of the
blood-brain barrier, a condition proposed to be instru-
mental for CNS degeneration and behavioral dysfunction
during lupus-like disease. Contrary to our expectation,
nonapoptotic mechanisms appear to predominate the
neuronal death in lupus mice.
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